Found 7 matching trials
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease PHASE2 The study evaluates the safety of different doses of a new medicine called ...
Show More Location
N America Res Inst - San Dimas
Learn More & Join Trial
A Research Study of a New Medicine NNC0519-0130 in Japanese and Non-Japanese Men PHASE1 NNC0519-0130 is a new medicine which may possibly help participants with ty...
Show More Location
SOUSEIKAI Sumida Hospital
Learn More & Join Trial
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight PHASE2 This study will look at how a new medicine called NNC0519-0130 helps people...
Show More Location
Centricity Research-Arizona
Learn More & Join Trial
A Research Study of the New Medicine NNC0519-0130 in Male Chinese Participants Living With Excess Body Weight PHASE1 Novo Nordisk is developing a new study medicine NNC0519-0130 to improve the...
Show More Location
Peking University Third Hospital, Northern Branch-Phase I
Learn More & Join Trial
A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes PHASE1 A new study medicine called NNC0519-0130 to improve treatment options for p...
Show More Location
Parexel International GmbH
Learn More & Join Trial
A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes. PHASE1 NNC0519-0130 is a new medicine which may possibly help participants with ty...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes PHASE2 This study will look at how well a new medicine called NNC0519-0130 helps p...
Show More Location
Velocity Clin Res-Chula Vista
Learn More & Join Trial